688621 Beijing Sun-Novo Pharmaceutical Research
- 49.40
- +0.29+0.59%
Beijing Sun-Novo Pharmaceutical Research News
Notice of shareholders, directors and supervisors terminating the agreed transfer plan and the share reduction plan
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Legal Opinions of Beijing Tianyuan Law Firm on the 2023 Annual General Meeting of Shareholders of Sunshine Nuohe
Announcement on the cancellation of the pledge of some shares of shareholders holding 5% or more of the shares
Announcement on the progress of the share transfer plan for shareholders holding 5% or more of the shares over half of the time
2023 and 2024 First Quarter Results and Cash Dividend Briefing Session Investor Relations Activity Record Form
Announcement on the pledge of some shares by shareholders holding 5% or more of the shares
2023 Annual General Meeting of Shareholders Meeting Materials
Investor Relations Activity Schedule for April 2024
2023 Annual Audit Report
2023 Environmental, Social and Governance (ESG) Report
Report on the performance of the Audit and Risk Committee of the Board of Directors in 2023
Verification report on the storage and use of raised funds
Special report on the storage and use of funds raised in 2023
Special inspection report of Minsheng Securities Co., Ltd. on the storage and use of funds raised by Beijing Sunshine Nuohe Pharmaceutical Research Co., Ltd. in 2023
Announcement of Resolutions of the 10th Meeting of the 2nd Board of Directors
2023 Annual Profit Distribution Plan Announcement
Announcement on the estimated application of comprehensive credit lines and guarantee amounts for companies and subsidiaries
Opinions of Minsheng Securities Co., Ltd. on the verification of Sunshine Novo and its subsidiaries applying for comprehensive credit lines and guarantee limits
Announcement on the “2024 Action Plan to Improve Quality, Increase Efficiency, and Value Rewards”
Analysis
Price Target
No Data
